This study uncovered for the first time that HNRNPA1-mediated 3′ UTR length changes of HN1 could contribute to cancer- and senescence-associated phenotypes, providing a new perspective to understand the molecular events underlying cancer and senescence, and indicating a potential target for cancer treatment as well. Here, HNRNPA1 is linked to cancer.